HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ferreira, T. Articles by Chevallier, J. Search for Related Content PubMed PubMed Citation Articles by Ferreira, T. Articles by Chevallier, J. Social Bookmarking                      What's this?

Volume 272, Number 15, Issue of April 11, 1997 pp. 9697-9702
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Functional Analysis of Mutated Purine-Cytosine Permease from Saccharomyces cerevisiae
A POSSIBLE ROLE OF THE HYDROPHILIC SEGMENT 371-377 IN THE ACTIVE CARRIER CONFORMATION

(Received for publication, December 4, 1996, and in revised form, February 4, 1997)

From the Institut de Biochimie et Génétique Cellulaires du Centre National de la Recherche Scientifique, UPR 9026, 1 rue Camille Saint-Saëns, F-33077 Bordeaux Cedex, France

The purine-cytosine permease (PCP) is an active transporter located in the plasma membrane of the yeast Saccharomyces cerevisiae. This protein mediates purine (adenine, guanine, and hypoxanthine) and cytosine accumulation in the cell by using an electrochemical potential difference in proton as the energy source.

Various mutant strains, with altered K_t(app) (apparent Michaelis constant of transport) of uptake for one or several bases, have already been selected. Their cloning and sequencing revealed that three of them presented substitutions in the same region of the putative sequence of the PCP: this region might correspond to the hydrophilic segment 371-377 (I-A-N-N-I-P-N). Two mutants displayed single mutations, resulting in only one amino acid residue change (N377I and N374I, respectively), and the other displayed three amino acid substitutions (I371V, I375V, and N377G). Therefore, to analyze the contribution of individual amino acid changes to the phenotype of the complex mutant, single (N377G) and double (I371V,I375V) mutants were constructed by site-directed mutagenesis.

The influence of single mutations in this region was studied by measuring, for adenine, hypoxanthine, and cytosine, the uptake constants on cells and equilibrium binding parameters on plasma membrane-enriched fractions. Uptake and binding constant determinations showed that all the variations observed for the K_t(app) of uptake were correlated with variations of the binding K_d(app) for the corresponding solutes. Thus, our results emphasize the role of the two asparagine residues, located at positions 374 and 377, respectively, in the binding of the bases. In addition, the sole substitution of the 377 asparagine residue by glycine is responsible for the phenotype of the triple mutant.

The effect of pH on the apparent hypoxanthine binding dissociation constant showed that the effects of N377G and N377I changes were, at least partially, due to a shift of the pK_a of an ionizable amino acid residue of the unliganded permease. These two amino acid residue changes induced a shift of the pK_a of this group in the unliganded, deprotonated permease about two units toward acidic pH. This result suggests that the 371-377 segment might play a key role in the proper three-dimensional structure of the active purine-cytosine permease.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Weyand, T. Shimamura, S. Yajima, S. Suzuki, O. Mirza, K. Krusong, E. P. Carpenter, N. G. Rutherford, J. M. Hadden, J. O'Reilly, et al. Structure and Molecular Mechanism of a Nucleobase-Cation-Symport-1 Family Transporter Science, October 31, 2008; 322(5902): 709 - 713. [Abstract] [Full Text] [PDF]

				P. Schwarz, G. Janbon, F. Dromer, O. Lortholary, and E. Dannaoui Combination of Amphotericin B with Flucytosine Is Active In Vitro against Flucytosine-Resistant Isolates of Cryptococcus neoformans Antimicrob. Agents Chemother., January 1, 2007; 51(1): 383 - 385. [Abstract] [Full Text] [PDF]

				R. Wagner, M.-L. Straub, J.-L. Souciet, S. Potier, and J. de Montigny New Plasmid System To Select for Saccharomyces cerevisiae Purine-Cytosine Permease Affinity Mutants J. Bacteriol., July 15, 2001; 183(14): 4386 - 4388. [Abstract] [Full Text] [PDF]